Neutrophil to Lymphocyte Ratio is Associated With Outcome During Ipilimumab Treatment☆
Sign Up to like & getrecommendations! Published in 2017 at "EBioMedicine"
DOI: 10.1016/j.ebiom.2017.03.029
Abstract: Background Ipilimumab (IPI) and BRAF inhibitors (BRAFi) improve survival in melanoma, but not all patients will benefit and toxicity can be significant. Pretreatment neutrophil to lymphocyte ratio (NLR) has been associated with outcome in IPI-treated… read more here.
Keywords: ipi; treatment; neutrophil lymphocyte; associated outcome ... See more keywords
Treatment Invasiveness and Illness Perceptions Are Strongly Associated With Outcome Expectations in Patients Treated for Hand or Wrist Conditions: A Cross-sectional Study
Sign Up to like & getrecommendations! Published in 2023 at "Clinical Orthopaedics and Related Research"
DOI: 10.1097/corr.0000000000002540
Abstract: Abstract Background Multiple studies have shown that more-positive outcome expectations are associated with better treatment outcomes. Although this has not been shown to represent a causal relationship, there nonetheless is an interest in positively modifying… read more here.
Keywords: treatment; associated outcome; outcome expectations; illness perceptions ... See more keywords
Ischemic stroke subtype is associated with outcome in thrombolyzed patients
Sign Up to like & getrecommendations! Published in 2017 at "Acta Neurologica Scandinavica"
DOI: 10.1111/ane.12589
Abstract: The impact of ischemic stroke subtype on clinical outcome in patients treated with intravenous tissue‐type plasminogen activator (IV‐tPA) is sparsely examined. We studied the association between stroke subtype and clinical outcome in magnetic resonance imaging… read more here.
Keywords: subtype associated; ischemic stroke; stroke subtype; associated outcome ... See more keywords
Peripheral Blood Biomarkers Associated With Outcome in Non-small Cell Lung Cancer Patients Treated With Nivolumab and Durvalumab Monotherapy
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2020.00913
Abstract: Background: Selecting patients who potentially benefit from immune checkpoint inhibitors (ICIs) is critical. Programmed death ligand-1 (PD-L1) protein immunohistochemical expression on cancer cells or immune cells and next-generation sequencing-based tumor mutational burden (TMB) are hot… read more here.
Keywords: durvalumab; associated outcome; blood; outcome non ... See more keywords